The shares of Acadia Healthcare Company Inc. (NASDAQ:ACHC) has been pegged with a rating of Equal-Weight by Stephens in its latest research note that was published on January 28, 2020. The Healthcare company has also assigned a $36 price target. Stephens wasn’t the only research firm that published a report of Acadia Healthcare Company Inc., with other equities research analysts also giving their opinion on the stock. The stock had earned Outperform rating from Raymond James Markets when it published its report on July 31, 2019. That day the Raymond James set price target on the stock to $45. The stock was given Hold rating by Deutsche Bank in its report released on January 03, 2019, the day when the price target on the stock was placed at 27. UBS was of a view that ACHC is Neutral in its latest report on November 16, 2018. Wells Fargo thinks that ACHC is worth Outperform rating.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 9 believe it has the potential for further growth, thus rating it as Hold while 5 advised investors to purchase the stock. The consensus currently stands at a Overweight while its average price target is $34.21. The price of the stock the last time has raised by 24.35% from its 52-Week high price while it is -61.05% than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 29.72.
The shares of the company added by 9.88% during the trading session on Wednesday, reaching a low of $11.90 while ending the day at $13.79. During the trading session, a total of 2.95 million shares were traded which represents a -257.25% decline from the average session volume which is 825590.0 shares. ACHC had ended its last session trading at $12.55. Acadia Healthcare Company Inc. currently has a market cap of $984.33 million, while its P/E ratio stands at 11.12, while its P/E earnings growth sits at 1.00, with a beta of 1.48. Acadia Healthcare Company Inc. debt-to-equity ratio currently stands at 1.28, while its quick ratio hovers at 1.20 ACHC 52-week low price stands at $11.09 while its 52-week high price is $35.40.
The company in its last quarterly report recorded $0.51 earnings per share which is above the predicted by most analysts. The Acadia Healthcare Company Inc. generated 124.19 million in revenue during the last quarter. In the second quarter last year, the firm recorded $0.52 earnings per share. Compared to the same quarter last year, the firm’s revenue was up by 23.53%. Acadia Healthcare Company Inc. has the potential to record 2.26 EPS for the current fiscal year, according to equities analysts.
It started the day trading at $3.50 and traded between $2.11 and $2.23 throughout the trading session.
A look at its technical shows that IMAC’s 50-day SMA is 1.04 while its 200-day SMA stands at 2.62. The stock has a high of $7.20 for the year while the low is $0.42. The stock, however, witnessed a rise in its short on 03/13/20. Compared to previous close which recorded 50675.04 shorted shares, the short percentage went higher by 114.21%, as 108,551 ACHC shares were shorted. At the moment, only 1.26% of IMAC Holdings Inc. shares were sold short. The company’s average trading volume currently stands at 810.78K shares, which means that the short-interest ratio is just 0.06 days. Over the past seven days, the company moved, with its shift of 374.77%. Looking further, the stock has raised 31.18% over the past 90 days while it lost -41.47% over the last six months.
This move now sees The The Vanguard Group, Inc. selling 0 shares in the last quarter, thus it now holds 38,906 shares of IMAC, with a total valuation of $38,517. Citadel Advisors LLC meanwhile bought more IMAC shares in the recently filed quarter, changing its stake to $18,856 worth of shares.
Similarly, SagePoint Financial, Inc. (Invest… decreased its IMAC Holdings Inc. shares by 0.00% during the recently filed quarter. After selling 4,800 shares in the last quarter, the firm now controls 0 shares of IMAC Holdings Inc. which are valued at $4,752. Following these latest developments, around 3.10% of IMAC Holdings Inc. stocks are owned by institutional investors and hedge funds.